The omission to home in on Billionaire Prem Watsa’s no-brainer stock pick despite a 24×7 vigil has cost us dearly and exposed severe chinks in our armour
ICICI-Direct’s Model Portfolio Of Large-Cap & Mid-Cap Stocks (July 2016)
ICICI-Direct has recommended a few top-quality Large-Cap & Mid-Cap Stocks for investment
Model Portfolio Of Mid Cap Marvels Stocks By Edelweiss (July 2016)
Edelweiss has recommended a Model Portfolio of seven top-quality mid-cap stocks for investment
Daljeet Kohli Revives Ashish Chugh’s Fav ‘Hidden Gem’ As Potential ‘Multibagger Stock’
When powerhouse stocks with impeccable management integrity, sound business model, debt-free status go into a downturn owing to macro issues, they should be bought aggressively. This is the staunch belief of Ashish Chugh and Daljeet Kohli, both of whom have mastered the fine art of finding winning stocks
Dharmesh Kant Recommends “High Quality Proxy Play” Stock With Huge Upside Potential
Dharmesh Kant, now with Motilal Oswal, is diligently discharging his responsibility of identifying winning stocks and recommending them to us. He has now homed in on a top-quality stock which stands to benefit from the demand for specialty chemicals and pharmaceuticals
NAMO Torpedoes Kenneth Andrade’s Latest Stock Pick & Sends It Plunging
Kenneth Andrade conducted a brilliant analysis of his latest stock pick. However, he lost sight of the fact that the Government calls the shots in the sector and is loath to let the corporate prosper at the cost of the impoverished farmers
Basant Maheshwari Rakes In Mega Bucks From “Rajnikant” Stock Even As PMS AUM Zooms
Basant Maheshwari’s stock picking mastery has enabled him to pocket mega gains from a “Rajnikant” style stock even as his PMS is growing in strength
Prof Sanjay Bakshi Hints That Market Is Overvalued & Warns Gloating Investors That Success May Be Short-Lived
Prof Sanjay Bakshi, the authority on value investing, has sent the timely warning that novice investors should not get carried away and become over exuberant as the markets appear to be overheated
Rahul Arora Of Nirmal Bang Foresees Mega Gains From Blue-Chip Pharma Stock
Rahul Arora of Nirmal Bang has recommended a blue-chip large-cap Pharma stock which has fallen from favour owing to USFDA issues. He claims that profits of the Company can “triple” and that the time is now opportune to buy the stock
Prof Sanjay Bakshi’s ValueQuest India Moat Fund Likely To See Better Days
Bloomberg has revealed important information relating to the AUM and returns of Prof Sanjay Bakshi’s ValueQuest India Moat Fund
Recent Comments